Karuna Therapeutics, Inc.
NASDAQ:KRTX
Overview | Financials
Company Name | Karuna Therapeutics, Inc. |
Symbol | KRTX |
Currency | USD |
Price | 329.83 |
Market Cap | 12,599,275,119 |
Dividend Yield | 0% |
52-week-range | 158.375 - 329.99 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. William Meury |
Website | https://www.karunatx.com |
An error occurred while fetching data.
About Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD